General Information of the Compound
| Compound ID |
CP0894314
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-3-ethyloxetan-3-yl 4-(5-((3-cyanopyridin-4-yl)methoxy)pyrimidin-2-yl)-3-methylpiperazine-1-carboxylate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H26N6O4
|
||||||||||||||||||
| Molecular Weight |
438.488
|
||||||||||||||||||
| Canonical SMILES |
CCC1(OC(=O)N2CCN(c3ncc(OCc4ccncc4C#N)cn3)[C@H](C)C2)COC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H26N6O4/c1-3-22(14-30-15-22)32-21(29)27-6-7-28(16(2)12-27)20-25-10-19(11-26-20)31-13-17-4-5-24-9-18(17)8-23/h4-5,9-11,16H,3,6-7,12-15H2,1-2H3/t16-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VIHHDUZIXQQMCS-MRXNPFEDSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02455, Glucose-dependent insulinotropic receptor
Protein ID: PT02398, Glucose-dependent insulinotropic receptor